The MMACHC variant c.158T>C: Mild clinical and biochemical phenotypes and marked hydroxocobalamin response in cblC patients
- 10 February 2024
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 142 (1) , 108345
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- PERCH: A Unified Framework for Disease Gene PrioritizationHuman Mutation, 2016
- Guidelines for diagnosis and management of the cobalamin‐related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiencyJournal of Inherited Metabolic Disease, 2016
- Clinical presentation and outcome in a series of 88 patients with the cblC defectJournal of Inherited Metabolic Disease, 2014
- Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and managementJournal of Inherited Metabolic Disease, 2011
- Inborn errors of cobalamin absorption and metabolismAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- Treatment of cobalamin C (cblC) deficiency during pregnancyJournal of Inherited Metabolic Disease, 2010
- Spectrum of mutations inMMACHC, allelic expression, and evidence for genotype–phenotype correlationsHuman Mutation, 2009
- Fetal dilated cardiomyopathy: an unsuspected presentation of methylmalonic aciduria and hyperhomocystinuria, cblC typePrenatal Diagnosis, 2009
- Neuropsychiatric Disturbances in Presumed Late-Onset Cobalamin C DiseaseArchives of Neurology, 2003
- Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiencyAnnals of Neurology, 2001